Financial regulation

Private Capital Markets Association President and Vice-Chair Craig Skauge Comments on OSC Developments

Retrieved on: 
Wednesday, July 20, 2022
Committee, TSX, OSC, Human, Confidentiality, National Post, Industry, Corporate governance, PCMA, CEO, Macintosh, Condominium, Government, Task force, The Globe and Mail, Integrity, Ford Motor Company, Small business, Board, Franco-Ontarian, Prospectus, Financial regulation, Law society, Osgoode, Leadership, Policy, Social Security Advisory Committee, Law, Ford government, Private, Toronto Stock Exchange, OPM, Lawyer, Regulation, Advisory Council, Mark (given name), Association, Growth, Dissent Channel, Financial adviser, Globe

The PCMA also lauds the Ford government for its publicly enunciated five-point plan to create confidence in Ontario's capital markets, its "open for business" policies as well the Ontario Capital Markets Modernization Taskforce's (Taskforce) independent recommendations as they pertain to capital formation in Ontario.

Key Points: 
  • The PCMA also lauds the Ford government for its publicly enunciated five-point plan to create confidence in Ontario's capital markets, its "open for business" policies as well the Ontario Capital Markets Modernization Taskforce's (Taskforce) independent recommendations as they pertain to capital formation in Ontario.
  • The composition of the recently announced Advisory Council to the CEO of the OSC only further cements this truth.
  • The Private Capital Markets Association of Canada (PCMA) is Canada's largest private capital markets community.
  • The PCMA is the national voice of the private capital markets in Canada with a focus on the exempt market.

Gambling.com Group Names Peter McGough Vice President of Investor Relations

Retrieved on: 
Monday, July 11, 2022
Marketing, Online, Casino, Gaming, Communications, Entertainment, GAMB, Cannabis, IGaming Business, Industry, Financial regulation, Business, Business administration, JPMorgan Chase, Corporation, View, McGough, Fordham, Multimedia, Technology, Acquisition, Bachelor of Business Administration, Group, Credit Suisse, S.A.C. Capital Advisors, VP, Culture, Investor relations, Management, Financial services

Gambling.com Group Limited (Nasdaq: GAMB) (Gambling.com Group or the Group), a leading provider of player acquisition services for the regulated global online gambling industry, today announced that Peter McGough joined Gambling.com Group as Vice President of Investor Relations, effective July 1, 2022.

Key Points: 
  • Gambling.com Group Limited (Nasdaq: GAMB) (Gambling.com Group or the Group), a leading provider of player acquisition services for the regulated global online gambling industry, today announced that Peter McGough joined Gambling.com Group as Vice President of Investor Relations, effective July 1, 2022.
  • McGough joins the Group from Viridian Capital Advisors, where he most recently served in an Institutional Sales role.
  • View the full release here: https://www.businesswire.com/news/home/20220711005165/en/
    Peter McGough, Gambling.com Group, Vice President of Investor Relations (Photo: Business Wire)
    Pete brings a wealth of experience and a fantastic network from his decades of experience in the New York finance community.
  • Having such a talented individual working inside the business, full-time and at the VP level will ensure we deliver a best-in-class investor relations program, said Charles Gillespie, Chief Executive Officer of Gambling.com Group.

Winston & Strawn's Expanding Miami Office Adds Two Partners: A Leading Corporate/Financial Services Lawyer and an Experienced Litigator

Retrieved on: 
Wednesday, June 29, 2022
New York State Department of Financial Services, Acquisition, Financial Regulatory Authority, Seafood mislabelling, Fraud, Financial regulation, LLP, Winston & Strawn, FINRA, Shutts & Bowen, Financial Crimes Enforcement Network, PATRIOT, Advertising, Federal, Bankruptcy, Dodd–Frank Wall Street Reform and Consumer Protection Act, Barclays, OCC, Compliance, Partnership, Federal Reserve, FDIC, Blockchain, International law, Winston, SEC, Financial services, Science and technology in Asia, Lawyer, OFAC, Knowledge, Asset, Architecture, Cryptocurrency, Bank, Greenberg

MIAMI, June 29, 2022 /PRNewswire/ -- Winston & Strawn LLP announced the addition of two partners to the firm's rapidly growing Miami office: Carl A. Fornaris, who joins the Transactions Department, and Jared R. Kessler, who joins the firm's Litigation Department.

Key Points: 
  • Accompanying these partners are Of Counsel Paul W. Jezierny, who joins the Transactions Department from Shutts & Bowen LLP's Miami office, and Associates Elisa H. Baca and Claudia Ojeda, who join the firm's Litigation Department from Greenberg's Miami office.
  • Associate Gabriela A. Plasencia joined the Transactions Department earlier this month from Shutts & Bowen in Miami.
  • These and other facets of the financial services sector are of key importance to the Miami and international business communities," said Miami Office Managing Partner Enrique J. Martin.
  • Winston & Strawn LLP is an international law firm with 16 offices in North America, South America, Asia, and Europe.

DGAP-News: Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of “Immune Evasive” Cells

Retrieved on: 
Wednesday, June 8, 2022
Stem cell, Implant, Company, Cell, Weizmann Institute of Science, Glucagon, Tel Aviv Stock Exchange, Neurodegeneration, Emeritus, Hope, IPSC, TASE, Financial regulation, Therapy, FDA, Patient, Insulin, Diabetes, Technology, ALS, Israel Prize, Projection, Risk, Immune system, Organoid, Immunosuppression, CSO, State Security Law in Bahrain, Transplant, Population, KDST, Molecular genetics, Regenerative medicine, Safety, Dentistry, Medical device, Pharmaceutical industry

If so, Implant Therapeutics iACTTM cells could be a good cell source for Kadimastem to create its glucose sensing, insulin producing pancreatic cells, the basis for IsletRx, without the need of Immune protection or immunosuppression.

Key Points: 
  • If so, Implant Therapeutics iACTTM cells could be a good cell source for Kadimastem to create its glucose sensing, insulin producing pancreatic cells, the basis for IsletRx, without the need of Immune protection or immunosuppression.
  • The iACTTM Immune Evasive cell technology uses genetic modifications to cloak cells to be seen as part of the receiving bodys immune system and therefore are not rejected following transplantation.
  • A successful evaluation may result in the licensing by Kadimastem of Implant Therapeutics technology.
  • Kadimastem CEO Asaf Shiloni said, This strategic agreement with Implant is the result of a long-term effort we have invested in bringing the innovative Immune Evasive cell technology to Kadimastem.

Governor Phil Scott appoints Sandy Bigglestone to lead captive industry

Retrieved on: 
Friday, June 3, 2022
Woman, Compliance, VP, Leadership, Regulation, Insurance, Advisory board, Regulatory compliance, Awareness, Financial regulation, DFR, Intelligence, Property, National Association, Partner (business rank), Division, Risk, National Association of Insurance Commissioners, Captive insurance, Thought, Industry, Department, University

MONTPELIER, Vt., June 3, 2022 /PRNewswire-PRWeb/ -- Governor Phil Scott has appointed Sandy Bigglestone to become the Deputy Commissioner of the Captive Insurance Division at the Department of Financial Regulation (DFR) at the end of the summer, ensuring a smooth transition in the role from current Deputy Commissioner David Provost, who is retiring. Bigglestone is currently the Director of Captive Insurance.

Key Points: 
  • It made sense to look within for the best person to lead the industry and the obvious choice was Sandy.
  • I look forward to all she will do moving forward in support of this great industry," said Governor Phil Scott.
  • In 2018, Bigglestone was the recipient of the Business Insurance Women to Watch Award for her leadership, expertise, and accomplishments in the captive insurance industry.
  • "The Vermont Captive industry and the broader captive sector will be served very well by Sandy Bigglestone," said John Prescott, Managing Partner, Johnson Lambert LLP.

Vermont captive insurance legislation is signed into law

Retrieved on: 
Thursday, June 2, 2022
Transfer, Risk management, Language, Insurance, Cell, Parametric, Delinquent, Commissioner, Legislation, CEO, Policy, Financial regulation, DFR, Risk, Association, Industry, Department, Organization, Symbiosis, Gold standard, Health insurance

SHELBURNE, Vt., June 2, 2022 /PRNewswire-PRWeb/ -- Governor Phil Scott signed new legislation into law modernizing Vermont's captive insurance statutes and removing inconsistencies. This year's bill, H.515, proposed several updates to Vermont's captive insurance law, including the ability for captive insurance companies to enter into parametric risk transfer contracts, simplifying reporting requirements, improving solvency procedures for sponsored cell captives, and clarifies an inconsistency related to the treatment of affiliated business in sponsored cell companies.

Key Points: 
  • SHELBURNE, Vt., June 2, 2022 /PRNewswire-PRWeb/ -- Governor Phil Scott signed new legislation into law modernizing Vermont's captive insurance statutes and removing inconsistencies.
  • Included in the captive bill this year was the passage of specific legislation that would allow for captive insurance companies to enter parametric risk transfer contracts.
  • "Vermont continues to take industry ideas and really consider those ideas," said Kevin Mead, President of the Vermont Captive Insurance Association.
  • "These smaller changes, when added up year after year, make all the difference for captive insurance companies," said Brittany Nevins, Captive Insurance Economic Development Director.

DGAP-News: Kadimastem Awarded Patent in Japan for AstroRx® For ALS and Drug Screening

Retrieved on: 
Monday, May 30, 2022
Diabetes, State Security Law in Bahrain, Company, Population, CSO, Parliament, Molecular genetics, Patient, Financial regulation, Weizmann Institute of Science, Regenerative medicine, TASE, Israel Prize, Clinical trial, Tel Aviv Stock Exchange, Emeritus, Cell, Stem cell, Patent, FDA, Projection, Brain, IND, Astrocyte, Spinal cord, Multiple sclerosis, Central nervous system, Technology, Safety, KDST, Risk, Movement, Japan Patent Office, ALS, Potency (pharmacology), Pharmaceutical industry

Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS, exploring one for multiple sclerosis and developing a potential cure for diabetes, has received a patent from the Japan Patent Office for AstroRx for the treatment of ALS and drug screening.

Key Points: 
  • Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS, exploring one for multiple sclerosis and developing a potential cure for diabetes, has received a patent from the Japan Patent Office for AstroRx for the treatment of ALS and drug screening.
  • Data showed that AstroRx delayed the progression of ALS by three months in ALSFRS-R measurement in both tested AstroRx doses.
  • In addition, we are exploring the possibilities of business partnerships with the pharmaceutical industry in Japan, both for AstroRx for ALS and IsletRx for diabetes.
  • AstroRx, the Company's lead product, is an astrocyte cell therapy in clinical development as a treatment for ALS.

Captive insurance deputy commissioner David Provost to retire

Retrieved on: 
Friday, May 27, 2022
Department, DoD Inspector General Distinguished Service Award, Family, Leadership, Goal, Distinguished Service Award, National Association of Insurance Commissioners, Gold standard, Humour, Long Trail, Captive insurance, DFR, American Discovery Trail, Industry, Retirement, Time, CICA, Heart, Applied linguistics, National Association, Financial services, Security (finance), Financial regulation, Maple syrup, Insurance, Whaling, Insurance

MONTPELIER, Vt., May 27, 2022 /PRNewswire-PRWeb/ -- Deputy Commissioner of the Captive Insurance Division at Vermont's Department of Financial Regulation (DFR), David Provost, has announced his plan to retire at the end of the summer to ensure a smooth transition within the Department to new leadership.

Key Points: 
  • David Provost has over 30 years of experience in captive insurance in both the private and government sectors.
  • He joined Vermont's then Department of Banking, Insurance, Securities and Health Care Administration in 2001 and was appointed to the role of Deputy Commissioner of the Captive Insurance Division in 2008 by then Governor James Douglas.
  • In Provost's time as Deputy Commissioner, Vermont's regulatory staff increased to 30 staff members, dedicated solely to captive insurance.
  • Provost licensed over 400 captive insurance companies in his time as Deputy Commissioner and had a hand in the formation of many more throughout his career.

Federal Home Loan Bank of Atlanta Announces New Member of its Affordable Housing Advisory Council

Retrieved on: 
Monday, May 23, 2022
Public policy, Brown University, Economics, Financial regulation, Treasury, United States Senate Committee on Banking, Housing, and Urban Affairs, United States Senate Committee on Commerce, Science, and Transportation, Certification, Bank, Insurance, Community Development Financial Institutions Fund, CDFI, Federal Home Loan Banks, NIIF, City, Council, Privacy Office of the U.S. Department of Homeland Security, Community development, Economic development, Community development financial institution, Columbia University, District, GLOBE, Housing

ATLANTA, May 23, 2022 (GLOBE NEWSWIRE) -- Federal Home Loan Bank of Atlanta (FHLBank Atlanta) announced today that it has appointed one new member to its Affordable Housing Advisory Council (Council).

Key Points: 
  • ATLANTA, May 23, 2022 (GLOBE NEWSWIRE) -- Federal Home Loan Bank of Atlanta (FHLBank Atlanta) announced today that it has appointed one new member to its Affordable Housing Advisory Council (Council).
  • FHLBank Atlantas Affordable Housing Advisory Council comprises 15 representatives from a diverse group of community and nonprofit organizations actively involved in providing or promoting low- and moderate-income housing and community lending within FHLBank Atlantas district.
  • FHLBank Atlanta is one of 11 district banks in the Federal Home Loan Bank System.
  • Since 1990, the FHLBanks have awarded approximately $7 billion in Affordable Housing Program funds, assisting more than 990,000 households.

Brenmiller Energy Ltd. Shares to Commence Trading on Nasdaq Capital Market; Closes Second Tranche of Private Placement Investment

Retrieved on: 
Tuesday, May 24, 2022
Environment, Utilities, Alternative Energy, Energy, Construction & Property, Building Systems, Hong Kong national security law, Form, Company, Private Securities Litigation Reform Act, Solel, Electric Bond and Share Company v. Securities and Exchange Commission, Financial regulation, Biomass, Risk, TASE, SEC filing, Shibboleth, Thermal energy storage, Tel Aviv Stock Exchange, Philip Morris International, Wind, Steam, Compliance, LinkedIn, SEC, Growth, Security (finance), CEO, Renewable energy, Nasdaq

Brenmiller Energy Ltd. (Brenmiller, Brenmiller Energy or the Company) (TASE: BNRG, Nasdaq: BNRG), a clean-energy company that provides Thermal Energy Storage (TES) systems to the global industrial and utility markets, announced today that its ordinary shares have been approved for listing on the Nasdaq Capital Market (Nasdaq).

Key Points: 
  • Brenmiller Energy Ltd. (Brenmiller, Brenmiller Energy or the Company) (TASE: BNRG, Nasdaq: BNRG), a clean-energy company that provides Thermal Energy Storage (TES) systems to the global industrial and utility markets, announced today that its ordinary shares have been approved for listing on the Nasdaq Capital Market (Nasdaq).
  • Brenmillers shares will begin trading on Nasdaq on Wednesday, May 25, 2022, under the ticker symbol BNRG.
  • The Company will maintain the listing of its ordinary shares on the Tel Aviv Stock Exchange under the symbol BNRG.
  • The listing of the Companys shares on the Nasdaq constitutes compliance with the closing requirements of a securities purchase agreement with certain private investors as previously announced on November 2, 2021.